115 related articles for article (PubMed ID: 2670694)
1. High-dose melphalan and autologous bone marrow support for treatment of ovarian carcinoma with positive second-look operation.
Dauplat J; Legros M; Condat P; Ferriere JP; Ben Ahmed S; Plagne R
Gynecol Oncol; 1989 Sep; 34(3):294-8. PubMed ID: 2670694
[TBL] [Abstract][Full Text] [Related]
2. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results.
Legros M; Dauplat J; Fleury J; Cure H; Suzanne F; Chassagne J; Bay JO; Sol C; Canis M; Condat P; Choufi B; Tavernier F; Glenat C; Chollet P; Plagne R
J Clin Oncol; 1997 Apr; 15(4):1302-8. PubMed ID: 9193321
[TBL] [Abstract][Full Text] [Related]
4. High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: a retrospective analysis of 35 patients treated in France.
Viens P; Maraninchi D; Legros M; Oberling F; Philip T; Herve P; Plagne R; Dufour P; Bergerat JP; Guastalla JP
Bone Marrow Transplant; 1990 Apr; 5(4):227-33. PubMed ID: 2337735
[TBL] [Abstract][Full Text] [Related]
5. A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma.
Weaver CH; Greco FA; Hainsworth JD; Zhen B; Baldwin P; Wittlin F; Lewis M; West WH; Schwartzberg L; Buckner CD
Bone Marrow Transplant; 1997 Nov; 20(10):847-53. PubMed ID: 9404925
[TBL] [Abstract][Full Text] [Related]
6. [Long-term clinical course after second laparotomy in ovarian cancer].
Stöckle E; Chauvergne J; Pigneux J; Avril A; Bussières E; Thomas L; Chevalier M; Marée D
Bull Cancer; 1990; 77(11):1087-98. PubMed ID: 2275986
[TBL] [Abstract][Full Text] [Related]
7. High dose melphalan and ABMT with or without abdominal radiotherapy as consolidation treatment for ovarian carcinoma in complete remission or with microscopic residual disease.
Dufour P; Bergerat JP; Liu KL; Bohbot A; Maloisel F; Duclos B; Herbrecht R; Faradji A; Jung JM; Oberling F
Eur J Gynaecol Oncol; 1991; 12(6):457-61. PubMed ID: 1809578
[TBL] [Abstract][Full Text] [Related]
8. Second-look laparotomy in managing epithelial ovarian carcinoma.
Dauplat J; Ferriere JP; Gorbinet M; Legros M; Chollet P; Giraud B; Plagne R
Cancer; 1986 Apr; 57(8):1627-31. PubMed ID: 3948133
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma.
Leff RS; Thompson JM; Johnson DB; Mosley KR; Daly MB; Knight WA; Ruxer RL; Messerschmidt GL
J Clin Oncol; 1986 Nov; 4(11):1586-91. PubMed ID: 3534154
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
11. High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer.
Donato ML; Gershenson DM; Wharton JT; Ippoliti CM; Aleman AS; Bodurka-Bevers D; Bevers MW; Burke TW; Levenback CF; Wolf JK; Freedman RS; Bast RC; Gajewski JL; Champlin RE
Gynecol Oncol; 2001 Sep; 82(3):420-6. PubMed ID: 11520135
[TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients.
Stiff PJ; Bayer R; Kerger C; Potkul RK; Malhotra D; Peace DJ; Smith D; Fisher SG
J Clin Oncol; 1997 Apr; 15(4):1309-17. PubMed ID: 9193322
[TBL] [Abstract][Full Text] [Related]
13. [Reassessment of second-look operations (SLO) in the treatment of ovarian cancer].
Ochiai K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1303-9. PubMed ID: 2730043
[TBL] [Abstract][Full Text] [Related]
14. Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.
Ayash LJ; Elias A; Schwartz G; Wheeler C; Ibrahim J; Teicher BA; Reich E; Warren D; Lynch C; Richardson P; Schnipper L; Frei E; Antman K
J Clin Oncol; 1996 Nov; 14(11):2984-92. PubMed ID: 8918496
[TBL] [Abstract][Full Text] [Related]
15. Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy.
Vincent MD; Powles TJ; Coombes RC; McElwain TJ
Cancer Chemother Pharmacol; 1988; 21(3):255-60. PubMed ID: 3282709
[TBL] [Abstract][Full Text] [Related]
16. Hexamethylmelamine and melphalan as salvage therapy in advanced ovarian carcinoma.
Tempero MA; Kessinger A
J Surg Oncol; 1982 Nov; 21(3):159-61. PubMed ID: 6813600
[TBL] [Abstract][Full Text] [Related]
17. Salvage therapy for recurrent and refractory ovarian cancer with high-dose chemotherapy and autologous bone marrow support: a Gynecologic Oncology Group pilot study.
Broun ER; Belinson JL; Berek JS; McIntosh D; Hurd D; Ball H; Williams S
Gynecol Oncol; 1994 Aug; 54(2):142-6. PubMed ID: 8063237
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
[TBL] [Abstract][Full Text] [Related]
19. High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors.
Mulder PO; Sleijfer DT; Willemse PH; de Vries EG; Uges DR; Mulder NH
Cancer Res; 1989 Aug; 49(16):4654-8. PubMed ID: 2545349
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT).
Ledermann JA; Herd R; Maraninchi D; Viens P; Buclon M; Philip T; Cure H; Lotz JP; Chauvin F; Ferrante P; Rosti G
Ann Oncol; 2001 May; 12(5):693-9. PubMed ID: 11432630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
